LINDSAY VEZINA: Open Payments
NPI 1518673003 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 35 payments from 20 companies in 2025. Trend: 2023 $373 · 2024 $663 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $248 |
| Novo Nordisk Inc | 10 | $241 |
| Edwards Lifesciences Corporation | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| PFIZER INC. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: Wegovy, AIRSUPRA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, SHINGRIX, Ozempic, PREVNAR 20, TRINTELLIX, LEQVIO.
Industry payments across CO — which companies pay providers there.
